Treatment Of Acute Myeloid Leukaemia According To The Hammersmith Protocol: Preliminary Report

Autor: Paolino, W., Resegotti, L., Rossi, M., Infelise, V.

Publikováno v: The British Medical Journal, 1973 Sep . 3(5880), 567-568.

Externí odkaz: https://www.jstor.org/stable/25421263

Will Molecular Biology Contribute to Refine Prognosis and to Select Treatment?

Autor: Zaccaria, A, Martinelli, G, Buzzi, M, Farabegoli, P, Saglio, G, Guerrasio, A, Bernabei, P, Santini, V, Pellicci, P, Mencarelli, A, Coco, F, Diverio, D, Rambaldi, A, Santoro, A, Tura, S, Russo, D, Zuffa, E, Fanin, R, Patriarca, F, Fiacchini, M, Baccarani, M, Testoni, N, Zamagni, M, Montefusco, E, Alimena, G, Meloni, G, Mandelli, F, Damiani, D, Michieli, M, Criscuolo, D, Fowst, C, Holdener, E, Specchia, G, Liso, V, Morra, E, Bernasconi, C, Demilio, A, Battista, R, Ditucci, A, Broccia, G, Maiolino, I, Caronia, F, Luciano, L, Rotoli, B, Leoni, P, Danieli, G, Bodenizza, C, Carotenuto, M, Rotondo, S, Nosari, A, Decataldo, F, Montuoro, A, Delaurenzi, A, Camillo, S, Liberati, A, Grignani, F, Tabilio, A, Martelli, M, Barbui, T, Leoni, F, Ciolli, S, Ronca, F, Nobile, F, Paolino, F, Resegotti, L, Papineschi, F, Spremolla, G, Landolfi, R, Leone, G, Volpe, E, Mangoni, L, Rizzoli, V, Capucci, A, Izzi, T, Scapoli, G, Castoldi, G, Gentilini, I, Coser, P, Gallo, E, Pileri, A, Cantonetti, M, Papa, G, Dini, D, Morandi, S, Bianchini, E, Pinotti, G, Venco, A, Zagonel, V, Pinto, A, Capaldi, A, Giovannelli, E, Pizzuti, M, Ricciuti, F, Ambrosetti, A, Cajozzo, A, Lombardo, M, Torlontano, G, Delfini, C, Lucarelli, G, Girino, M, Ascari, E, Risso, M, Damasio, E, Martino, S, Pardini, S, Longinotti, M, Miraglia, E, Debiase, R, Nardelli, S, Galieni, P, Dispensa, E, Abbadessa, A, Bruzzese, L, Prossomariti, L, Cimino, R, Derosa, C, Gabbas, A, Francesco, S, Gallamini, A, Difrancesco, A, Quaglino, D, Musolino, C, Squadrito, G, Avanzini, P, Gobbi, F, Nuova, A, Emilia, R, Aglietta, M, Camaschella, C, Mazza, M, Guglielmo, P, Cacciola, E, Monaco, M

Publikováno v: Leukemia & Lymphoma. 11:81-89

The possible prognostic value of the position of the breakpoint within the M-BCR in patients with Phl+ CML is still being debated. We analyzed the DNA rearrangements and the transcript types of 244 patients and tried to correlate the data obtained wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fd81cfca223236b191198e9776e4285
https://doi.org/10.3109/10428199309047869

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes

Autor: Ferrini, PR, Grossi, A, Vannucchi, AM, Barosi, G, Guarnone, R, Piva, N, Musto, P, Balleari, E, Castoldi,G, Rigolin, GM, Rossi, PF, Fabbri, A, Leoni, F, Ghio, R, Maiolo, AT, Cortelezzi, A, Calori, R, Morra, E, Cairoli, R, Gabbas, A, Cicalo, F, Rizzoli, V, Caramatti, C, Bernasconi, C, Bonfichi, M, Ascari, E, Carotenuto, M, Resegotti, L, Degani, G, Perona, G, Nadali, G

To evaluate the effect of recombinant human erythropoietin (rHuEpo) on the haemoglobin level and transfusion requirement in low-risk myelodysplastic syndromes (MDS), 87 patients were enrolled in a randomized doubleblind placebo-controlled study. 44 p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1299::330538b46cfd80ec7b0b70dae162e6d7
https://hdl.handle.net/10281/408753

Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas

Autor: Guglielmi, C., Martelli, M., Federico, M., Zinzani, Pl, Vitolo, U., Bellesi, G., Santini, G., Tarella, Corrado, Zallio, F., Pregno, P., DI RENZO, N., Resegotti, L.

Our aim was to identify risk factors in adults with diffuse large cell lymphoma at first relapse.We studied 474 patients observed at 45 centers in Italy. Median time from diagnosis to relapse was 395 days, median age at relapse was 55 years and media

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3f09221180bc1bf530fc7573257ce2a6
http://hdl.handle.net/11573/256378

The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial

Autor: De Witte, T, Suiciu, S, Zittoun, R, Resegotti, L, Liso, V, Willemze, R, Belhabri, A, Amadori, S, Guistolisi, R, Labar, B, Fioritoni, G, Rossi-Ferrini, G, Leone, G, Jehn, U, Keating, S, Fazi, P, Rodts, P, Solbu, G, Mandelli, F.

xx

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::81d88d4f508d4f0d8acdf98c2b7ddbf3
https://www.bib.irb.hr/68779